Morning Market Movers By: Benzinga via Benzinga September 24, 2014 at 09:40 AM EDT Lipocine (NASDAQ: LPCN) shares gained 76.44% to $9.21 after the company reported positive top-line results in its Phase 3 study of LPCN ... Read More >> Related Stocks: Acorda Therapeutics Baxter International Bed Bath & Beyond Electromed Inc Inovio Pharma Lipocine Inc Micronet Enertec Tec